Cupid Ltd, the Nashik-based healthcare products maker, is betting big on its consumer-facing business this year, with plans to cross the ₹100-crore revenue mark in its fast-moving consumer goods (FMCG) vertical and expand retail coverage to 1.8 lakh outlets across India. The announcement was made by Chairman and Managing Director Aditya Kumar Halwasiya during the company’s annual general meeting on Friday.
Halwasiya told shareholders that the company is on track to deliver its strongest quarter ever in Q2 of FY26, citing a mix of fresh product launches, a healthy pipeline of institutional orders, and the scaling of its FMCG division. Cupid, long recognized for its range of contraceptives, is repositioning itself as a broader consumer wellness and health-tech brand, with a focus on preventive care and personal wellness.
In FY25, Cupid reported total income of ₹203 crore, with FMCG contributing just over ₹50 crore. The company now expects the category to double in FY26. “This outlook positions us for record performance while laying the groundwork for sustainable expansion across multiple business lines,” Halwasiya said.
Key launches lined up for the current fiscal include flavored and dotted condoms, mini packs of petroleum jelly, and a premium deodorant range for women. Alongside new products, Cupid is commissioning a modern manufacturing plant, which will serve as a next-generation production hub.
Halwasiya emphasized that growth will be driven by both consumer demand and institutional contracts, ensuring balanced revenues. He added that Cupid’s long-term strategy is to make preventive healthcare and wellness solutions more accessible across markets, while simultaneously pursuing opportunities for international expansion.
With the FMCG business set to double and retail penetration widening significantly, Cupid is preparing to transform its brand perception and broaden its consumer base in FY26.
